lithium gluconate
lithium D-gluconate
Identification
| Name | lithium gluconate |
| IUPAC | lithium;(2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoate |
| CAS Number | 60816-70-8 |
| EINECS | 262-443-8 |
| FDA UNII | 29L5I58185 |
| Molecular Formula | C6 H11 Li O7 |
| Molecular Weight | 202.08907000 |
| Nikkaji Number | J268.297D |
Regulatory
Physical Properties
| Assay | 95.00 to 100.00 |
| Food Chemicals Codex Listed | No |
| Soluble in | water, 1e+006 mg/L @ 25 °C (est) |
Cosmetic Information
| CosIng | cosmetic data |
| Cosmetic Uses | skin conditioning |
No sensory data available
Safety Information
| Oral/Parenteral Toxicity | Not determined |
| Dermal Toxicity | Not determined |
| Inhalation Toxicity | Not determined |
GHS Classification
['GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)', 'GHS Label elements, including precautionary statements']
Safety in Use
| Category | cosmetic ingredient for skin conditioning |
| Recommendation for lithium gluconate usage levels up to | not for fragrance use. |
| Recommendation for lithium gluconate flavor usage levels up to | not for flavor use. |
BOC Sciences
Best of Chemicals Supplier
Quality supplier of research chemicals and biochemicals including inhibitors, building blocks, GMP Products, impurities and metabolites, APIs for Veterinary, Natural Compounds, ADCs, Stem Cell Molecul...
Potential Uses
Natural Occurrence
Synonyms
D-
gluconic acid, lithium salt (1:1)
lithium D-gluconate
lithium;(2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoate
PubMed:
Anti-inflammatory effects of lithium gluconate on keratinocytes: a possible explanation for efficiency in seborrhoeic dermatitis.
PubMed:
[Lithium gluconate 8% in the treatment of seborrheic dermatitis].
PubMed:
[Lithium].
PubMed:
Lithium gluconate 8% vs ketoconazole 2% in the treatment of seborrhoeic dermatitis: a multicentre, randomized study.
PubMed:
Lithium gluconate in the treatment of seborrhoeic dermatitis: a multicenter, randomised, double-blind study versus placebo.
PubMed:
The effects of lamotrigine on the pharmacokinetics of lithium.
PubMed:
Familial hypokalaemic periodic paralysis: prevention of paralytic attacks with lithium gluconate.
PubMed:
[Crystalline inclusions of the mouse thyroid. Effect of chronic treatment with lithium gluconate].
PubMed:
[Ultrastructural modifications in the thyroid glands of mice treated with lithium gluconate].
PubMed:
[Evaluation of the potential cardiotoxicity of propranolol-lithium gluconate association (author's transl)].
PubMed:
[Cardiac electrophysiological effects of lithium gluconate in anesthetized dogs].
PubMed:
[Do lithium salts have a place in the treatment of severe hyperthyroidism? (author's transl)].
PubMed:
[Treatment of drug-resistant depressive states with lithium gluconate].
PubMed:
[Lithium gluconate: systematic and factorial analysis of 104 cases which have been studied for 2 and one-half to 3 years in patients regularly observed and showing periodic cyclothymia or dysthymia].
PubMed:
[Modifications of serum creatine phosphokinase activity under the influence of lithium gluconate in Duchenne's myopathy].
PubMed:
[Lithium gluconate in emotional disturbances (preliminary results; current orientation)].
PubMed:
[Remarkable thymoanaleptic effect of lithium gluconate in recurrent melancholic states].